Frat Jean-Pierre, Le Pape Sylvain, Coudroy Rémi, Thille Arnaud W
Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers, France.
Centre d'Investigation Clinique 1402 ALIVE, INSERM, Université de Poitiers, Poitiers, France.
Int J Gen Med. 2022 Apr 7;15:3121-3132. doi: 10.2147/IJGM.S294906. eCollection 2022.
High-flow nasal oxygen and noninvasive ventilation are two alternative strategies to standard oxygen in the management of acute respiratory failure.
Although high-flow nasal oxygen has gained major popularity in ICUs due to its simplicity of application, good comfort for patients, efficiency in improving oxygenation and promising results in patients with acute hypoxemic respiratory failure, further large clinical trials are needed to confirm its superiority over standard oxygen. Non-invasive ventilation may have deleterious effects, especially in patients exerting strong inspiratory efforts, and no current recommendations support its use in this setting. Protective non-invasive ventilation using higher levels of positive-end expiratory pressure, more prolonged sessions and other interfaces such as the helmet may have beneficial physiological effects leading to it being proposed as alternative to high-flow nasal oxygen in acute hypoxemic respiratory failure. By contrast, non-invasive ventilation is the first-line strategy of oxygenation in patients with acute exacerbation of chronic lung disease, while high-flow nasal oxygen could be an alternative to non-invasive ventilation after partial reversal of respiratory acidosis. Questions remain about the target populations and non-invasive oxygen strategy representing the best alternative to standard oxygen in acute hypoxemic respiratory failure. As concerns acute on-chronic-respiratory failure, the place of high-flow nasal oxygen remains to be evaluated.
在急性呼吸衰竭的管理中,高流量鼻导管吸氧和无创通气是标准氧疗的两种替代策略。
尽管高流量鼻导管吸氧因其应用简便、患者舒适度高、改善氧合效果显著以及在急性低氧性呼吸衰竭患者中取得了有前景的结果,在重症监护病房(ICU)中已广受欢迎,但仍需进一步的大型临床试验来证实其优于标准氧疗。无创通气可能有有害影响,尤其是在吸气用力较强的患者中,目前尚无推荐支持在此情况下使用。采用更高水平呼气末正压、更长治疗时间以及使用头盔等其他接口的保护性无创通气可能具有有益的生理效应,这使其被提议作为急性低氧性呼吸衰竭中高流量鼻导管吸氧的替代方法。相比之下,无创通气是慢性肺病急性加重患者氧疗的一线策略,而在呼吸性酸中毒部分纠正后,高流量鼻导管吸氧可作为无创通气的替代方法。关于急性低氧性呼吸衰竭中代表标准氧疗最佳替代方案的目标人群和无创氧疗策略仍存在疑问。至于慢性呼吸衰竭急性加重,高流量鼻导管吸氧的地位仍有待评估。